# Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects

> **NCT02456558** · PHASE1 · COMPLETED · sponsor: **ApoPharma** · enrollment: 30 (actual)

## Conditions studied

- Asymptomatic HIV Infection

## Interventions

- **DRUG:** Intravenous deferiprone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02456558
- **Lead sponsor:** ApoPharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-03
- **Final completion:** 2016-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02456558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02456558, "Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02456558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*